In this scenario the deviation seen in the BC allele frequencies of the TP53 and HRAS SNPs away from their expected 50% may be explained by a variable contribution to the circulating BC from the mosaic haematopoietic progenitor cell population. The gene discussed is TP53; the disease is breast cancer.